亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Effects of dronedarone on all-cause mortality and on cardiovascular events in patients treated for atrial fibrillation: a meta-analysis of RCTs

医学 决奈达隆 心房颤动 优势比 荟萃分析 随机对照试验 内科学 心脏病学 胺碘酮 冲程(发动机) 子群分析 置信区间 机械工程 工程类
作者
Renato De Vecchis,Carmelina Ariano
出处
期刊:Minerva Cardioangiologica [Edizioni Minerva Medica]
卷期号:67 (2) 被引量:2
标识
DOI:10.23736/s0026-4725.18.04719-9
摘要

The efficacy and safety profiles of the dronedarone were rather praised when the molecule was placed on the market (2009). However, there are today some safety concerns (in particular, risk of liver toxicity) that have led to limit the use of this drug to paroxysmal or persistent atrial fibrillation, and to exclude it from therapy protocols for ventricular tachyarrhythmias. The aim of the present study was to explore some efficacy and safety endpoints concerning dronedarone, by analyzing the evidence derived from quantitative evaluation (meta-analysis) of literature data.We comprised in the meta-analysis exclusively randomized controlled trials (RCTs) that reported relevant clinical outcomes with dronedarone. In addition, eligible RCTs had to have randomized 100 patients at least in order to have adequate statistical power, and they had to have clearly reported the outcomes of interest. Primary efficacy outcomes were a) all-cause mortality,b) major acute cardiovascular events and c) worsening heart failure. Secondary outcomes of interest were ventricular tachyarrhythmias, stroke and systemic embolism. We performed a number of sensitivity analyses to better ascertain the sources of heterogeneity. We also performed a number of subgroup analyses.At the end of the selection process, the studies regarded suitable for meta-analysis were seven. Dronedarone use was not associated with any significant advantage as regards all-cause mortality(pooled odds ratio =1.31; 95% CI: 0.78 to 2.18; P= 0.31) and major cardiovascular events (pooled odds ratio=1.45; 95% CI: 0.7 to 3.01; P=0.28), as well as regarding the endpoint" worsening heart failure" (pooled odds ratio =1.32; 95% CI: 0.87 to 2.01; P= 0.20). Moreover, using subgroup analyses, in patients with permanent AF, dronedarone use was associated with increased all-cause mortality compared to placebo(P=0.03),as well as with higher risk of major acute cardiovascular events (P=0.04) and episodes of worsening heart failure(P=0.02). In addition, when data from ATHENA study were excluded, dronedarone use was associated with increased all-cause mortality (post exclusion pooled odds ratio=1.77; 95% CI: 1.15 to 2.72; P=0.0089), increased risk of major cardiovascular events (post exclusion pooled odds ratio=2.16; 95% CI: 1.34 to 3.47; P= 0.0014) and increased risk of worsening heart failure(post exclusion pooled odds ratio= 1.618; 95% CI: 1.14 to 2.3; P=0.006).In our meta-analysis, dronedarone did not provide any significant benefit with regard to all-cause mortality and major cardiovascular events, as well as regarding the risk of worsening heart failure. Sensitivity analyses then showed that the exclusion of a study, namely ATHENA study, caused a shift in the overall odds ratio, so as to convert the dronedarone use to the ominous role of predictor of higher mortality, worse cardiovascular morbidity and increased risk of worsening heart failure. Thus, dronedarone should be used with caution as second-line medication and exclusively for the secondary prevention of paroxysmal or persistent atrial fibrillation, in patients without signs or symptoms of cardiac decompensation, preferably for limited periods of time and under assiduous clinical and laboratory surveillance.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
21秒前
失眠的修杰完成签到,获得积分10
23秒前
整齐的诗筠完成签到,获得积分10
33秒前
46秒前
1分钟前
温暖的忆霜完成签到,获得积分10
1分钟前
执着忆寒完成签到,获得积分10
1分钟前
YZY完成签到 ,获得积分10
1分钟前
隐形依秋完成签到,获得积分10
1分钟前
1分钟前
义气慕梅完成签到,获得积分10
1分钟前
清脆妙梦完成签到,获得积分10
2分钟前
爱听歌的碧彤完成签到,获得积分10
2分钟前
Xuezhuoxin完成签到,获得积分10
2分钟前
2分钟前
年轻凌丝完成签到,获得积分10
2分钟前
自然的烨霖完成签到,获得积分10
2分钟前
闫伏龙发布了新的文献求助30
2分钟前
physicalpicture完成签到,获得积分10
3分钟前
科研通AI65的应助被York Chang采纳,获得10
3分钟前
闫伏龙完成签到,获得积分10
3分钟前
大气钧完成签到,获得积分10
3分钟前
Mojoko完成签到,获得积分10
3分钟前
领导范儿的应助被科研通管家采纳,获得10
3分钟前
孤独难胜完成签到,获得积分10
3分钟前
寒冷的映冬完成签到,获得积分10
4分钟前
Canmiyo完成签到 ,获得积分10
4分钟前
武汉出血王完成签到,获得积分10
4分钟前
外向的慕山完成签到,获得积分10
4分钟前
腼腆的如南完成签到,获得积分10
5分钟前
超级笑柳完成签到,获得积分20
5分钟前
lwroche完成签到,获得积分10
5分钟前
傻傻的含莲完成签到,获得积分10
5分钟前
科研民工完成签到,获得积分10
5分钟前
搞怪的盛男完成签到,获得积分10
6分钟前
万能图书馆的应助被amiee采纳,获得10
6分钟前
开心饼干完成签到,获得积分10
6分钟前
6分钟前
兴奋的疾完成签到,获得积分10
7分钟前
7分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185231
求助须知:如何正确求助?哪些是违规求助? 9574100
关于积分的说明 21834203
捐赠科研通 7782763
什么是DOI,文献DOI怎么找? 3434531
关于科研通互助平台的介绍 2558801
邀请新用户注册赠送积分活动 2481237